journal cover

Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis

Case Reports in Immunology

Oct 12, 2016

Matthew Chak Hin SzetoAndrzej Piotrowicz

Get paper from

Abstract

Tocilizumab is an interleukin-6 receptor inhibitor licensed for moderate to severe rheumatoid arthritis (RA). We report a case of Tocilizumab monotherapy for severe active RA in a patient with coexisting ulcerative colitis (UC). The patient was intolerant to multiple disease-modifying d...read more

Mentioned in this Paper

Laboratory Studies
Study
Interleukin 6 Receptor
Tocilizumab
Interleukin 6 Measurement
Clinical Trial [Publication Type]
Clinical Trials
Glucocorticoids
Gastrointestinal Neoplasms
Anti-Inflammatory Agents, Non-Steroidal
Paper Details
References

Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis

Case Reports in Immunology

Oct 12, 2016

Matthew Chak Hin SzetoAndrzej Piotrowicz

PMID: 27818807

DOI: 10.1155/2016/7562123

Abstract

Tocilizumab is an interleukin-6 receptor inhibitor licensed for moderate to severe rheumatoid arthritis (RA). We report a case of Tocilizumab monotherapy for severe active RA in a patient with coexisting ulcerative colitis (UC). The patient was intolerant to multiple disease-modifying d...read more

Mentioned in this Paper

Laboratory Studies
Study
Interleukin 6 Receptor
Tocilizumab
Interleukin 6 Measurement

Related Papers

Paper Details
References

Get paper from

/papers/successful-use-of-tocilizumab-in-a-patient-with/27818807